Dublin, Feb. 07, 2019 (GLOBE NEWSWIRE) -- The "Genetic Testing - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering. Global Genetic Testing market accounted for $7749.00 million in 2017 and is expected to reach $25948.46 million by 2026 growing at a CAGR of 14.37% during the forecast period. Factors such as rise in the incidence of genetic diseases and increase in the prevalence of cancer and cardiovascular diseases are fuelling the market growth. Moreover, demand in the benefits offered by genetic testing (such as specificity and early identification) is one of the major opportunities to boost the market during the forecast period. However, inaccuracies in results and reimbursement issues are restricting the growth of the market. A genetic test is used to determine the DNA sequence of a certain region of the human genome. This region might be a whole gene or a share of a gene, or other areas thought to regulate genes. The test will look for certain changes in the sequence that is known to have consequences on the function of a gene. Mostly genetic tests are performed on a DNA sample, because every tissue in the body is composed of cells that contain DNA. By type, predictive & pre-symptomatic testing segment acquired significant growth due to increase in awareness about diseases such as cancer and early detection of diseases. Based on end user, hospital based laboratories segment is owing to user convenience and increasing number of hospitals are a few factors projected to propel the hospital-based laboratories segment during the forecast period. On the basis of geography, North America is considered as the fastest growing market and the factors favouring the growth of this region are developed infrastructure, increase in health care investments, and robust R&D activities in these countries. What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements.
Key Topics Covered: 1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.5 Research Sources 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Technology Analysis 3.7 Application Analysis 3.8 End User Analysis 3.9 Emerging Markets 3.10 Futuristic Market Scenario 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Genetic Testing Market, By Technology 5.1 Introduction 5.2 Biochemical Testing 5.3 Cytogenetic testing 6 Global Genetic Testing Market, By Disease 6.1 Introduction 6.2 Alzheimer Disease 6.3 Cystic Fibrosis 6.4 Huntington Disease 6.5 Duchenne Muscular Dystrophy 6.6 Sickle Cell Anemia 6.7 Cancer Disease 6.8 Thalassemia 6.9 Special Diseases 6.10 Other Diseases 7 Global Genetic Testing Market, By Type 7.1 Introduction 7.2 Predictive & Pre-symptomatic Testing 7.3 Carrier Testing 7.4 Nutrigenomic Testing 7.5 Forensic Testing 7.6 Newborn and Prenatal Testing 7.6.1 Preimplantation Genetic Diagnosis 7.6.2 Diagnostic Techniques 7.6.2.1 Fluorescence in situ hybridization (FISH) 7.6.2.2 Polymerase chain reaction (PCR) 7.6.2.3 Comparative genomic hybridization (CGH) 7.6.3 Screening Methods 7.6.3.1 Maternal serum screening (MSS) 7.6.3.2 Noninvasive prenatal testing (NIPT) 7.7 Molecular Genetic Test/ DNA Test 7.7.1 Direct Sequencing 7.7.2 DNA Microarray Analysis 7.7.3 Chromosomal Genetic Test 7.7.4 Other Molecular Genetic Test/ DNA Tests 7.8 Tandem Mass Spectrometry 7.9 High-performance liquid chromatography 7.10 Gas Chromatography/ Mass Spectrometry 7.11 Other Types 8 Global Genetic Testing Market, By Testing Sample 8.1 Introduction 8.2 Saliva 8.3 Hair 8.4 Blood 8.5 Tumors 8.6 Other Testing Samples 9 Global Genetic Testing Market, By Application 9.1 Introduction 9.2 Cancer Genetic Testing 9.3 Prescribed Genetic Testing 9.4 Pharmacogenomics Genetic Testing 9.5 Predisposition Cancer Genetic Testing 9.6 Direct to consumer (DTC) Genetic Testing 9.7 Neurogenetic Disorder Testing 9.8 Muscular Dystrophies 9.9 Other Applications 10 Global Genetic Testing Market, By End User 10.1 Introduction 10.2 Blood Bank 10.3 Hospitals 10.4 Nursing Homes 10.5 Laboratories 10.6 Specialty clinics 10.7 Other End Users 11 Global Genetic Testing Market, By Geography 11.1 Introduction 11.2 North America 11.3 Europe 11.4 Asia Pacific 11.5 South America 11.6 Middle East & Africa 12 Key Developments 12.1 Agreements, Partnerships, Collaborations and Joint Ventures 12.2 Acquisitions & Mergers 12.3 New Product Launch 12.4 Expansions 12.5 Other Key Strategies 13 Company Profiling 13.1 Illumina Inc 13.2 Abbott Laboratories 13.3 BGI Tech 13.4 Thermo Fisher Sceintific 13.5 Luminex Corporation 13.6 Cepheid 13.7 Qiagen N.V 13.8 Blueprint Genetic 13.9 Pacific Biosciences of California Inc 13.10 Affymetrix 13.11 Bio-Rad Laboratories 13.12 Celera Group 13.13 AutoGenomics Inc. 13.14 Roche Diagnostics Limited 13.15 Molecular Inc. 13.16 Genomictre Inc 13.17 HTG Molecular Diagnostics Inc 13.18 Oxford Biodynamics Ltd 13.19 Roche Holding AG 13.20 National Center for Biotechnology Information For more information about this report visit https://www.researchandmarkets.com/research/p...netic?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Genomics
